Current Treatment for Viral Upper Respiratory Infection
Symptomatic therapy is the appropriate management strategy for viral upper respiratory infections, and antibiotics should not be prescribed as they are ineffective and lead to significantly increased risk for adverse effects. 1
Understanding Viral URIs
Viral upper respiratory infections (URIs), commonly known as the common cold, are self-limited illnesses that typically include some or all of the following symptoms:
- Sneezing
- Rhinorrhea (runny nose)
- Sore throat
- Cough
- Low-grade fever
- Headache
- Malaise
These symptoms are dependent on the host's inflammatory response to the particular viral infection. Multiple viruses can cause URIs, with transmission occurring through direct hand contact, contact with contaminated surfaces, or airborne droplets.
Treatment Algorithm for Viral URIs
First-line Management: Supportive Care
Patient Education:
- Inform patients that symptoms can last up to 2 weeks 1
- Advise follow-up if symptoms worsen or exceed the expected recovery time
- Explain that antibiotics are not needed and may cause harm
Symptomatic Relief Options:
- Analgesics for pain and antipyretics for fever 1
- Combination products containing antihistamines, analgesics, and decongestants (1 in 4 patients experiences significant symptom relief) 1
- Decongestants like pseudoephedrine for temporary relief of nasal congestion and sinus pressure 2
- Antitussives like dextromethorphan for cough due to throat irritation 3
- Other options that may provide relief:
- Inhaled ipratropium bromide
- Inhaled cromolyn sodium
- Saline nasal irrigation
- Systemic or topical decongestants
- Mucolytics
- Intranasal corticosteroids
- Antihistamines (tailored to specific symptoms) 1
Zinc Supplements:
- May reduce duration of symptoms if administered within 24 hours of symptom onset
- Benefits must be weighed against adverse reactions like nausea and bad taste 1
Important Considerations
- No evidence supports the use of vitamins (including vitamin C) or herbal remedies such as echinacea 1
- Antibiotics should not be prescribed for viral URIs as they provide no benefit and increase risk of adverse effects 1
- Handwashing is the best method to reduce spread, as the most efficient means of transmission is direct hand contact 1
Special Populations
Immunocompromised Patients
- Nucleic acid-based testing for viral pathogens may be considered in immunocompromised patients at high risk for death from respiratory viral infection 1
- In select cases of RSV infection, ribavirin may be considered for immunocompromised patients (e.g., stem cell transplant patients) with potentially life-threatening infections 1
Common Pitfalls to Avoid
Unnecessary Antibiotic Prescribing:
- Approximately 30% of common cold visits result in an antibiotic prescription despite clear evidence against their use 1
- Antibiotics should be reserved only for cases with clear bacterial infection
Failure to Set Appropriate Expectations:
- Not informing patients that symptoms can last up to 2 weeks
- Not providing guidance on when to follow up if symptoms worsen
Overreliance on Unproven Remedies:
- Recommending vitamins or herbal supplements without evidence of efficacy
Confusing Viral URI with Bacterial Sinusitis:
- Bacterial sinusitis should only be considered with:
- Persistent symptoms for more than 10 days
- Severe symptoms with high fever (>39°C) and purulent nasal discharge or facial pain for at least 3 consecutive days
- Worsening symptoms following a typical viral illness that was initially improving (double sickening) 1
- Bacterial sinusitis should only be considered with:
By following this evidence-based approach to managing viral URIs, clinicians can provide appropriate symptomatic relief while avoiding unnecessary antibiotic use and its associated harms.